Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Cell Calcium. 2011 Dec 26;51(2):131–139. doi: 10.1016/j.ceca.2011.11.011

Figure 4.

Figure 4

Effect of the selective TRPV4 agonist, GSK101, on M-1 cell [Ca2+]i levels. A. Typical [Ca2+]i trace from one coverslip (average of 10 cells) showing effect of TRPV4 activation following addition of 10 nM GSK101. The [Ca2+]i response is slightly biphasic reaching a peak within 1–6 minutes. B. Summary of GSK101 affects on [Ca2+]i (n=7). C. Representative time course showing the effect of GSK101 on [Ca2+]i in the presence and absence of extracellular Ca2+ (0 Ca2+). Note the abrupt increase in [Ca2+]i following re-introduction of Ca2+ with prior treatment by GSK101. D. Summary of the affect of GSK101 on the peak change in the F340/F380 ratio in the presence and absence of 0 Ca2+ (-Ca2+, n = 2) and HC-067047 (100 nM, n = 4). *P<0.05.